Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2015-12-04 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
关于2015年度非公开发行股票摊薄即期回报对公司主要财务指标的影响及公司采取措施的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Inner Mongolia Jinyu Group Co., Ltd. regarding the impact of a 2015 non-public stock issuance on the company's key financial indicators and the measures taken by the company. It details the planned private placement, the use of proceeds, assumptions about the issuance, and the expected dilution effect on earnings per share and return on equity. It also discusses risk warnings and company responses to mitigate the dilution impact. The document is focused on capital raising activities and their financial impact, not a full financial report or earnings release. It is not a full Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is not a regulatory filing or certification. The content fits best under Capital/Financing Update (CAP) as it provides detailed information about a capital raising event and its financial implications.
2015-12-04 Chinese
第八届董事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Inner Mongolia Jinyu Group Co., Ltd. It details decisions made by the board regarding capital reserve conversion to share capital, adjustments to private placement stock issuance price and quantity, and the impact of private placement on financial indicators. It includes voting results and references other announcements for detailed content. The document is not a full financial report, earnings release, or regulatory filing but a formal announcement of board resolutions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board.
2015-12-04 Chinese
第八届监事会第二十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Inner Mongolia Jinyu Group Co., Ltd. It details the meeting date, attendance, and the approval of a resolution regarding the use of funds from a non-public stock issuance. The document is short (407 characters) and serves as an official announcement of a board meeting decision rather than a full report or detailed financial disclosure. It does not contain financial statements, audit information, or detailed management discussion. It is not a report publication announcement since it contains the actual resolution content. This fits best under Regulatory Filings (RNS), which is the fallback category for official announcements that do not fit other specific categories.
2015-12-04 Chinese
关于最近五年被证券监管部门和交易所采取监管措施或处罚及整改情况的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from Inner Mongolia Jinyu Group Co., Ltd. regarding regulatory measures, penalties, and rectification actions taken by securities regulatory authorities and stock exchanges over the past five years. It includes references to regulatory notices, supervisory letters, and corrective measures related to corporate governance, internal controls, financial management, and information disclosure. The document does not contain financial statements or comprehensive financial performance data typical of annual or interim reports. Instead, it focuses on regulatory compliance, supervisory feedback, and company responses to regulatory concerns. This type of content aligns with a Regulatory Filings (RNS) classification, as it is a general regulatory announcement and compliance document that does not fit into more specific categories like Annual Report or Audit Report. The document length (8947 characters) and detailed regulatory content further support this classification rather than a brief announcement or report publication notice.
2015-12-04 Chinese
关于第八届董事会第十五次会议及第八届监事会第十六次会议决议公告的更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement regarding previous disclosures about the use of funds raised from a non-public stock issuance. It references prior announcements of board and supervisory meetings and a shareholders' meeting, clarifying discrepancies in the stated use of proceeds. The document does not contain financial statements or detailed financial data but serves to correct and clarify previously published meeting resolutions and announcements. It is not a full report, earnings release, or financial supplement but an official correction to prior disclosures. Therefore, it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and corrections that do not fit other categories.
2015-12-04 Chinese
关于全资子公司签订猪瘟疫苗联合研制协议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by Inner Mongolia Jinyu Group Co., Ltd. regarding a joint research and development agreement signed by its wholly-owned subsidiary for a swine fever vaccine. It details the parties involved, the content of the agreement, responsibilities, costs, cooperation period, impact on the company, and risk warnings. There are no financial statements, earnings data, or regulatory certifications. The document is a corporate announcement about a business cooperation agreement, not a financial report, management change, or legal proceeding. It fits best as a general regulatory announcement about a material business development that does not fall into other specific categories.
2015-12-03 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.